Young Investigator Award 2018 (2,000 CHF)
We are pleased to announce that the “2018 Cancers Young Investigator Award” is now open for applications. All nominations will be assessed by an Evaluation Committee led by the
Prof. Dr. Samuel C. Mok
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Eligibility and Requirements:
–– Hold an earned Ph.D. or M.D. degree.
–– Be 40 years age or under (as of 31 December 2018).
–– Conduct ground-breaking research, making a significant contribution to the advancement of cancer research.
–– Priority will be given to applicants who have published papers in Cancers.
List of Documents for Nominations:
–– Detailed Curriculum Vitae including an updated publication list and a list of the researcher’s research grants.
–– List of conferences the candidate will attend (the conference name and its website).
–– Scanned copy of doctorate certificate.
–– Signed nomination letters from two established senior scientists.
The award will consist of:
–– 2000 Swiss Francs.
–– An offer to publish a paper free of charge without a fixed deadline in Cancers after peer review.
–– An engraved plaque.
Please send your nominations and materials at the link www.mdpi.com/journal/cancers/awards by 31 December 2018. The winner will be announced by February 2019.
Travel Award 2017
As Editor-in-Chief of the open access journal Cancers, it is my pleasure to announce that the winner of the 2017 Cancers Travel Award is Dr. Cecilia Leung, Ph.D. Dr. Leung is a postdoctoral researcher in Prof. Giulio Draetta’s laboratory at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
On behalf of Cancers, she will be supported with 1000 Swiss Francs towards travel expenses to attend the American Association for Cancer Research (AACR) Annual Meeting 2017 to be held at Washington, D.C., USA.
Dr. Leung’s current research focuses on epigenetic regulation of pancreatic cancer progression. Using pooled shRNA epigenome library, she and her colleagues performed an in vivo loss-of-function screen and identified COMPASS-like complexes, which have specific H3K4 methyltransferase activity, to be key oncogenic drivers of pancreatic cancer. Dr. Leung has co-authored ten publications of which three are as first author, many in high profile journals (such as Nature Communications, Cancer Research and Clinical Cancer Research). She has also already been the recipient of numerous awards.
Prof. Samuel C. Mok